Point72 Asia (Singapore) Pte. Ltd. Novo Cure LTD Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Novo Cure LTD stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 6,901 shares of NVCR stock, worth $122,975. This represents 0.05% of its overall portfolio holdings.
Number of Shares
6,901
Previous 1,893
264.55%
Holding current value
$122,975
Previous $29.6 Million
595.02%
% of portfolio
0.05%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding NVCR
# of Institutions
291Shares Held
75.7MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$216 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$210 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$158 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$85.8 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$48.8 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.87B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...